TRANSITION THERAPEUTICS INC's ticker is TTHI and the CUSIP is 893716209. A total of 21 filers reported holding TRANSITION THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $132,000 | -22.4% | 19,102 | -24.7% | 0.00% | – |
| Q2 2014 | $170,000 | -1.2% | 25,356 | +17.4% | 0.00% | – |
| Q1 2014 | $172,000 | +3.0% | 21,597 | -26.5% | 0.00% | – |
| Q4 2013 | $167,000 | +119.7% | 29,379 | +58.1% | 0.00% | – |
| Q3 2013 | $76,000 | – | 18,587 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 4,863,914 | $10,214,000 | 1.24% |
| Birchview Capital, LP | 145,746 | $306,000 | 0.16% |
| DAFNA Capital Management LLC | 59,222 | $124,000 | 0.10% |
| HOLLENCREST CAPITAL MANAGEMENT | 162,196 | $341,000 | 0.05% |
| VESTOR CAPITAL, LLC | 42,600 | $89,000 | 0.03% |
| Plante Moran Financial Advisors, LLC | 17,034 | $36,000 | 0.03% |
| SABBY MANAGEMENT, LLC | 302,837 | $636,000 | 0.02% |
| SPHERA FUNDS MANAGEMENT LTD. | 70,273 | $148,000 | 0.01% |
| FineMark National Bank & Trust | 22,807 | $48,000 | 0.01% |
| Alyeska Investment Group, L.P. | 394,858 | $830,000 | 0.01% |